EXHIBIT 10.1
EX-10.1
Exhibit 10.1
SILEXION THERAPEUTICS CORP
May 15, 2026
Holder of Ordinary Share Purchase Warrants
| Re: | Inducement Offer to Exercise Ordinary Share Purchase Warrants |
Dear Holder:
Silexion Therapeutics Corp (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) (i) the opportunity to receive new warrants to purchase ordinary shares of the Company, par value $0.0135 per share (the “Ordinary Shares”) and (ii) a reduction in the Exercise Price (as defined in the respective Existing Warrants) of the Ordinary Share purchase warrants issued on August 1, 2025 (the “August Existing Warrants”), the Series A Ordinary Share purchase warrants issued on September 12, 2025 (the “Series A Existing Warrants”), and Series B Ordinary Share purchase warrants issued on September 12, 2025 (the “Series B Existing Warrants”) set forth on Exhibit A hereto (collectively, the “Existing Warrants”) held by you in consideration for exercising by you
…